Skip to content

Latest Post

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning
  • Sun. Nov 22nd, 2026
MedGadget.in logo – medical technology news and healthcare technology insights

  • Home
  • About Us
  • Author
  • Contact Us
Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…

Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb

A CDSCO expert panel recommended a Phase I trial of Indian Immunologicals' live attenuated Zika vaccine, developed with Griffith University and funded by ICMR.

Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb

PMV Pharmaceuticals' rezatapopt produced a 48% response rate in platinum-resistant ovarian cancer with TP53 Y220C in the pivotal PYNNACLE trial, with an FDA filing planned…

Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb

Mayo Clinic data from ObesityWeek 2026 show GLP-1 users with weakened hearts saw greater one-year gains in heart structure and function than matched non-users, with…

Healthcare Services

Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning

November 21, 2026 Simone Lamb

Up to 15 people have died and more than 300 have sought care in Imphal after drinking spurious liquor in Manipur's Chandel district. What we…

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn…

Uncategorized

Pharming Reports Positive Phase II Results for Leniolisib in Rare Immune Disorders

September 23, 2026 Simone Lamb

Pharming has reported positive Phase II results for leniolisib in rare PI3Kδ-linked primary immunodeficiencies, showing a 26.4% mean spleen volume reduction in a 13-patient trial, with a larger CVID trial…

Uncategorized

Karnataka FDA Hits 24 Drug Licences in Major Counterfeit-Medicine Crackdown

September 22, 2026 Simone Lamb

Karnataka's FDA has cancelled 16 drug licences and suspended eight more, including a Pfizer C&F depot, after uncovering a counterfeit-medicine racket that relabeled low-cost drugs as expensive life-saving injectables worth…

Uncategorized

Intuitive Introduces Next-Generation da Vinci 5 Robotic Surgery System in India

September 21, 2026 Simone Lamb

Intuitive has launched its da Vinci 5 robotic surgery system in India, cleared for urologic, gynecologic, general, cardiac and thoracoscopic surgery, adding first-of-its-kind Force Feedback technology to a platform already…

Uncategorized

AIIMS Delhi Transfers India-Trained AI Mammography Technology to BPL for Clinical Development

September 21, 2026 Simone Lamb

AIIMS Delhi has transferred its AI-based mammography interpretation model to BPL Medical Technologies for further development and clinical validation, aiming to bring specialist-level breast cancer screening support to India's tier…

Uncategorized

Centre Begins Talks on Trade-Margin Rationalisation for Medical Devices and Hospital Consumables

September 20, 2026 Simone Lamb

India's Centre has started stakeholder talks with the medical device industry and private hospitals on trade-margin rationalisation, after Maharashtra's FDA flagged markups up to 2,841% on hospital consumables like IV…

Uncategorized

White House Reportedly Considers Direct Political Oversight of NIH Research Grants

September 20, 2026 Simone Lamb

Trump has reportedly directed OMB Director Russell Vought to draft an executive order creating a board, including NIH Director Jay Bhattacharya, with unanimous final authority over NIH grant funding, following…

Uncategorized

AI Health Insurer Angle Health Raises $600 Million at $2.7 Billion Valuation

September 20, 2026 Simone Lamb

Angle Health, an AI-native health benefits platform for small businesses founded by ex-Palantir engineers, has raised $600 million led by Vitruvian Partners at a $2.7 billion valuation, more than doubling…

Uncategorized

All 50 US States Join Trump’s New Medicaid International Drug-Pricing Model

September 19, 2026 Simone Lamb

All 50 states, DC, and Puerto Rico have applied to join the Trump administration's GENEROUS Medicaid drug-pricing model, which ties prices to what other developed nations pay, with projected savings…

Uncategorized

FDA Approves Lilly’s Inluriyo Plus Verzenio Combination for ESR1-Mutated Advanced Breast Cancer

September 19, 2026 Simone Lamb

The FDA has approved Eli Lilly's Inluriyo (imlunestrant) plus Verzenio (abemaciclib) for ER-positive, HER2-negative, ESR1-mutated advanced breast cancer, doubling median progression-free survival to 11.1 months in the Phase 3 EMBER-3…

Uncategorized

ByteDance’s AI Drug-Discovery Spinout Anew Labs Raises $290 Million at a $1.5 Billion Valuation

September 19, 2026 Simone Lamb

ByteDance has raised $290 million for Anew Labs, its AI drug-discovery spinout, at a $1.5 billion valuation in its first external funding round, with ByteDance retaining a 56% stake and…

Posts pagination

1 … 32 33 34 … 36

You missed

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb
Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb
Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb
Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb
MedGadget.in logo – medical technology news and healthcare technology insights

Proudly powered by WordPress | Theme: NewsTwenty by Themeansar.

  • Home
  • About Us
  • Author
  • Contact Us